跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
WELIREG belzutifan 40 mg film-coated tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
WELIREG belzutifan 40 mg film-coated tablet blister pack
Approved
STANDARD
WELIREG belzutifan 40 mg film-coated tablet blister pack
Merck Sharp & Dohme (Australia) Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Jun 28, 2025
Approval ID
7b82cf60e914b797
Company
Merck Sharp & Dohme (Australia) Pty Ltd
Type
Standard
Approval Details
Approval Id
7b82cf60e914b797
Product Name
WELIREG belzutifan 40 mg film-coated tablet blister pack
Artg Id
482705
Artg Name
WELIREG belzutifan 40 mg film-coated tablet blister pack
Sponsor
Merck Sharp & Dohme (Australia) Pty Ltd
Company Detail Path
/organization/merck-sharp-and-dohme-australia-pty-ltd
Artg Date
2025-06-25
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Jun 28, 2025
Approval ID
7b82cf60e914b797
Type
Standard
Back to TGA Approvals
